Journal of Reproduction & Infertility

Journal of Reproduction & Infertility

Evaluation of essential time to reach to mature follicle following ovulation stimulation with clomiphene citrate

Authors
Mahnaz Ashrafi 1
Narges Salehi 2
Mariya Sadeghi 3
1 Department of Obstet . and Gynecol Faculty of Medicine, Iran Medical Sciences University, Tehran, Iran
2 Department of Obstet . and Gynecol Alavi Hospital, Ardabil, Ardabil, Iran
3 Infertility Research group of Royan Institute, Tehran, Iran
Abstract
Ovulation disorders and unexplained infertility are most common infertility causes among women. The first line treatment in these cases is clomiphene citrate. This study has been designed to evaluate the essential time for growth follicle to reach 18 mm of diameter among patients who were stimulated to ovulate with clomiphene citrate. Study was experimental type and 78 women with polycystic ovary syndrome and 92 women with unexplained infertility referring to Royan Institute had taken to this study. These persons were under treatment with clomiphene citrate 100mg from day of 5-9 of menstrual cycle and follicular growth monitoring was performed by vaginal ultrasonograghy. The necessary time for follicular growth was determined separately in patients with polycystic ovary disease and unexplained infertility and its correlation with age, duration of infertility, BMI and hirsutism was studied in both groups. There was no significant association between the essential time for follicular growth groups and in both groups it was day of 14 of cycle and length of this time had no significant correlation with age, duration of infertility, hirsutism and BMI. There were more common cases of no response to follicle as absence of follicular growth or progesterone serum level less than 5ng/ml in patients with polycystic ovary syndrome. Since the average time of follicle growth in patients with PCO and unexplained infertility who were stimulated to ovulate with clomiphene citrate was the day 14 of the cycle in this study, it has been suggested in cases that follicular growth monitoring with ultrasonography or evaluation of LH peak in urine is not possible, the continuation of treatment can be scheduled on the basis that patients with have a mature follicle on day 14 of their cycle.
Keywords
Follicular growth
Polycystic ovary syndrome
Ultrasonography
Unexpained infertility
Shoham Z., Weissman A. Polycystic ovarian disease: obesity and insulin resistance. Proc IFFS. 1998; 263-72.
Franks S. Polycystic ovary syndrome. N Engl J Med. 1995; 333: 853-61.
Carr B.R., Blackwell R.E. Textbook of reproductive medicine. 2nd Edition, appleton and lange. 1998; 389-404, 565-82.
Speroff R.H, Glass N.G. Clinical gynecologic endocrinology and infertility. 6th Edition, Lippincott Williams & Wilkins. 1999; 487-522, 1097-132
Berek J.S., Adashi E.Y., Hillard P.A. Novak,s Gynecology. 12th Edition. 1996; 915-62.
Dickey R.P., Olar T.T. Clomiphene citrate–induced intrauterine insemination cycles. Assis Reprod Rev. 1993; 3: 108-20.
Hammond M.G., Halme J.K., Talbert L.M. Factors affecting the pregnancy rate in clomiphene citrate induction of ovulation. Obs Gyn. 1983; 62(2): 196-202.
Opsahl M.S., Robins E.D., O, conner D.M., et al. Characteristics of gonadotropin response, follicular development, and endometrial growth and maturation across consecutive cycles of clomiphene citrate treatment. Fertil Steril. 1996; 66: 533-9.
Gorlisky G.A., Kase N.G., Speroff L. Ovulation and pregnancy rates with clomiphene citrate. Obs Gyn. 1978; 51: 265-9.
Makler A., De Cherney A., Naftolin F. A device for injecting and retaining a small volume of concentrated spermatozoa in the uterine cavity and cervical canal. Fertil Steril. 1984; 42: 306-8.
Royston J. Basal body temperature, ovulation, and the risk of conception with special reference to the life spans of sperm and egg. Biometrics. 1982; 38: 397-402.
Nachtigall M., Arici A. LH Monitoring methods and intrauterine insemination. Assis Reprod Rev. 1993; 03: 136-40.
Yolanda R., John F.R., Ansbacher D.M., et al. Comparison of low-technology and high technology monitoring of clomiphene citrate ovulation induction. Fertil Steril.
Andersen A.G., Als Nielsen B., Hornnes P.J., et al. Time interval from human chorionic gonadotropin (HCG) injection to follicular rupture. Hum Reprod. 1995; 10: 3202-5.
MacGregor A.H., Johnson J.E., Bunde C.A. Furthes clinical experience with clomiphene citrate. Fertil Stril. 1968; 19: 616.
Garcia J.E., Jones G.S., Wentz A.C. The use of clomiphene citrate. Fertil Stril. 1977; 28: 707.
Gysler M., March C.M., Mishell D.R., et al. A decade’s experience with an individualized clomiphene treatment regimen including its effect on postcoital test. Fertil Steril. 1982; 37: 161.
Ransom S.B., Dombrowski M.P., Gene Mc Neeley S., et al. Practical strategies in obstetrics and Gynecology. 1st Edition. Saunders. 2000; 539-50.
Polson D.W., Deborah S., Kiddy, et al. Induction of ovulation with clomiphene citrate in women with polycystic ovary syndrome: the difference between responders and nonresponders.Fertil Steril. 1989; 51: 30-4.
Imani B., Marinus J.C., Eijkeman S., et al. Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheik infertility. J Clin Endocrinol Metab. 1998; 83: 2361-5.
Journal of Reproduction & Infertility
Volume 2, Issue 3
Summer 2001
Pages 41-47